Diabetes Research and Clinical Practice
Volume 90, Issue 2 , Pages 147-153 , November 2010

Predictors of success to weight-loss intervention program in individuals at high risk for type 2 diabetes

  • Weilin Kong

      Affiliations

    • Division of Endocrinology, Department of Medicine, University of Sherbrooke, Sherbrooke, Quebec, Canada
  • ,
  • Marie-France Langlois

      Affiliations

    • Division of Endocrinology, Department of Medicine, University of Sherbrooke, Sherbrooke, Quebec, Canada
    • Centre de recherche clinique Étienne-Le Bel, Centre hospitalier universitaire de Sherbrooke, Sherbrooke, Quebec, Canada
  • ,
  • Carole Kamga-Ngandé

      Affiliations

    • Division of Endocrinology, Department of Medicine, University of Sherbrooke, Sherbrooke, Quebec, Canada
  • ,
  • Claudia Gagnon

      Affiliations

    • Division of Endocrinology, Department of Medicine, University of Sherbrooke, Sherbrooke, Quebec, Canada
  • ,
  • Christine Brown

      Affiliations

    • Centre de recherche clinique Étienne-Le Bel, Centre hospitalier universitaire de Sherbrooke, Sherbrooke, Quebec, Canada
  • ,
  • Jean-Patrice Baillargeon

      Affiliations

    • Division of Endocrinology, Department of Medicine, University of Sherbrooke, Sherbrooke, Quebec, Canada
    • Centre de recherche clinique Étienne-Le Bel, Centre hospitalier universitaire de Sherbrooke, Sherbrooke, Quebec, Canada
    • Corresponding Author InformationCorresponding author at: Division of Endocrinology, University of Sherbrooke, Sherbrooke, Qc J1H 5N4, Canada. Tel.: +1 819 564 5244; fax: +1 819 564 5292.

Received 16 March 2010 ,Revised 4 June 2010 ,Accepted 29 June 2010.

References 

  1. Overweight, obesity, and health risk. National Task Force on the Prevention and Treatment of Obesity. Arch Intern Med 2000;160:898–904.
  2. Pan XR, Li GW, Hu YH, Wang JX, Yang WY, An ZX, et al. Effects of diet and exercise in preventing NIDDM in people with impaired glucose tolerance. The Da Qing IGT and Diabetes Study. Diabetes Care. 1997;20:537–544
  3. Tuomilehto J, Lindstrom J, Eriksson JG, Valle TT, Hamalainen H, Ilanne-Parikka P, et al. Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance. N Engl J Med. 2001;344:1343–1350
  4. Linde JA, Jeffery RW, Levy RL, Pronk NP, Boyle RG. Weight loss goals and treatment outcomes among overweight men and women enrolled in a weight loss trial. Int J Obes (Lond). 2005;29:1002–1005
  5. Linde JA, Rothman AJ, Baldwin AS, Jeffery RW. The impact of self-efficacy on behavior change and weight change among overweight participants in a weight loss trial. Health Psychol. 2006;25:282–291
  6. Knowler WC, Barrett-Connor E, Fowler SE, Hamman RF, Lachin JM, Walker EA, et al. Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. N Engl J Med. 2002;346:393–403
  7. Lau DC, Douketis JD, Morrison KM, Hramiak IM, Sharma AM, Ur E. 2006 Canadian clinical practice guidelines on the management and prevention of obesity in adults and children [summary]. CMAJ. 2007;176:S1–13
  8. Kamga-Ngande CN, Carpentier AC, Nadeau-Marcotte F, Ardilouze JL, Baillargeon JP, Bellabarba D, et al. Effectiveness of a multidisciplinary program for management of obesity: the Unite d’Enseignement, de Traitement et de Recherche sur l’Obesite (UETRO) database study. Metab Syndr Relat Disord. 2009;7:297–304
  9. Lindstrom J, Eriksson JG, Valle TT, Aunola S, Cepaitis Z, Hakumaki M, et al. Prevention of diabetes mellitus in subjects with impaired glucose tolerance in the Finnish Diabetes Prevention Study: results from a randomized clinical trial. J Am Soc Nephrol. 2003;14:S108–S113
  10. Lindstrom J, Ilanne-Parikka P, Peltonen M, Aunola S, Eriksson JG, Hemio K, et al. Sustained reduction in the incidence of type 2 diabetes by lifestyle intervention: follow-up of the Finnish Diabetes Prevention Study. Lancet. 2006;368:1673–1679
  11. Elfhag K, Rossner S. Who succeeds in maintaining weight loss? A conceptual review of factors associated with weight loss maintenance and weight regain. Obes Rev. 2005;6:67–85
  12. Teixeira PJ, Going SB, Sardinha LB, Lohman TG. A review of psychosocial pre-treatment predictors of weight control. Obes Rev. 2005;6:43–65
  13. Teixeira PJ, Going SB, Houtkooper LB, Cussler EC, Metcalfe LL, Blew RM, et al. Pretreatment predictors of attrition and successful weight management in women. Int J Obes Relat Metab Disord. 2004;28:1124–1133
  14. Teixeira PJ, Going SB, Houtkooper LB, Cussler EC, Martin CJ, Metcalfe LL, et al. Weight loss readiness in middle-aged women: psychosocial predictors of success for behavioral weight reduction. J Behav Med. 2002;25:499–523
  15. Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III). JAMA 2001;285:2486–97.
  16. ATS statement: guidelines for the six-minute walk test. Am J Respir Crit Care Med 2002;166:111–7.
  17. Norcross JC, Prochaska JO. Using the stages of change. Harv Ment Health Lett. 2002;18:5–7
  18. Hulens M, Vansant G, Claessens AL, Lysens R, Muls E. Predictors of 6-minute walk test results in lean, obese and morbidly obese women. Scand J Med Sci Sports. 2003;13:98–105
  19. Hulens M, Vansant G, Lysens R, Claessens AL, Muls E. Exercise capacity in lean versus obese women. Scand J Med Sci Sports. 2001;11:305–309
  20. Sackett DL, Haynes RB, Guyatt GH, Tugwell P. Clinical epidemiology—how to do clinical practice research. 3rd ed.. Philadelphia: Lippincott Williams and Wilkins; 2005;
  21. Deeks JJ, Altman DG. Diagnostic tests 4: likelihood ratios. BMJ. 2004;329:168–169

 Data previously presented at the following meeting: The Endocrine Society's 91st Annual meeting, P2-414. Washington DC, June 2009 (poster abstract).

PII: S0168-8227(10)00333-5

doi: 10.1016/j.diabres.2010.06.031

Diabetes Research and Clinical Practice
Volume 90, Issue 2 , Pages 147-153 , November 2010